Dianthus Therapeutics DNTH Share Based Compensation Expense — General And Administrative Expense

Other product segments

Similar metrics at other companies

MANEReportable Segment — General and administrative, personnel expenses (including share-based compensation)

$4.33M+936%

PTGXSingle Reportable — General And Administrative Expense Excluding Employee Expense Benefit And Allocation Share Based Compensation Expenses

$5.7M+2.9%

WYNNGeneral and administrative — Stock-based compensation expense

$15.59M-9.9%

TGTXNon Cash Compensation Selling General And Administrative Expenses

$15.08M+29.5%

PAYCGeneral And Administrative Expense Benefit

$69.4M+5.2%

EMATCorporate — Selling General And Administrative Expense

-$15.13M-440%

Questions, answered.

What is Dianthus Therapeutics's share based compensation expense — general and administrative expense?

Dianthus Therapeutics (DNTH) reported share based compensation expense — general and administrative expense of $5.75M in Q1 2026.

How has Dianthus Therapeutics's share based compensation expense — general and administrative expense changed year-over-year?

Dianthus Therapeutics's share based compensation expense — general and administrative expense increased by 102.6% year-over-year, from $2.84M to $5.75M.

What does share based compensation expense — general and administrative expense mean?

This metric captures the share-based compensation expense attributed to general and administrative functions, including executive management, legal, finance, and corporate operations. It quantifies the non-cash compensation cost associated with supporting the company's overall corporate infrastructure and overhead. Analyzing this figure provides insight into the cost of administrative talent and the impact of equity-based incentive programs on corporate operating expenses.